SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021597
Filing Date
2022-11-03
Accepted
2022-11-03 09:00:58
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20220930.htm   iXBRL 10-Q 3328075
2 EX-10.1 lbph-ex10_1.htm EX-10.1 96741
3 EX-31.1 lbph-ex31_1.htm EX-31.1 22216
4 EX-31.2 lbph-ex31_2.htm EX-31.2 22229
5 EX-32.1 lbph-ex32_1.htm EX-32.1 23282
6 GRAPHIC img8596771_0.jpg GRAPHIC 404100
  Complete submission text file 0000950170-22-021597.txt   13887196

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20220930_lab.xml EX-101.LAB 404620
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20220930_pre.xml EX-101.PRE 307488
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20220930_def.xml EX-101.DEF 167424
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20220930_cal.xml EX-101.CAL 38865
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20220930.xsd EX-101.SCH 44250
59 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20220930_htm.xml XML 3482502
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 221356450
SIC: 2834 Pharmaceutical Preparations